GLP-1s

GLP-1s are a class of prescription drugs that mimic a hormone to regulate appetite and blood sugar, primarily used for managing type 2 diabetes and obesity.

Why it’s in the news: They are in the news due to soaring demand driven by their effectiveness for weight loss, leading to their adoption as 'lifestyle drugs' and new, off-label uses.

Latest on GLP-1s

• GLP-1s could offer unexpected relief from back and knee pain, but doctors urge caution
• STAT+: Once described as obesity medicines for ‘patients,’ GLP-1s are increasingly lifestyle drugs for ‘customers’
• STAT+: Pharmalittle: We’re reading about GLP-1s becoming lifestyle drugs, a setback for Merck and Daiichi, and more
• Telemedicine company offers GLP-1s for addiction
• Lilly’s revenue soars 48%, driven by demand for its GLP-1s
• Just About Anyone Can Sell You GLP-1s Online Now

Connections

6 entities linked to GLP-1s across the news graph.